Company Presentation

MUVON Therapeutics AG is a Swiss clinical stage biotech company with the goal of revolutionizing the treatment of various diseases caused by muscle damage or degradation through the use of the patients’ own cells. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to regain control over their life.